Animal Cell Therapies, Inc. is pleased to announce the appointment of Robert Sabes as chairman of its Business Advisory board.

San Diego – February 12, 2012 – Animal Cell Therapies (ACT), a company specializing in scientific based veterinary stem cell treatments and products, announced today the appointment of Robert Sabes as chairman of its Business Advisory Board.

Possessing decades of investment and management experience in a wide variety of industries, Robert Sabes currently presides as the Chairman and Chief Executive Officer of RW Sabes Enterprises.

“Animal Cell Therapies welcomes the wealth of business expertise that Mr. Sabes provides as chairman of our business advisory board,” said Dr. Kathryn Petrucci, founder of Animal Cell Therapies, Inc.”

About Animal Cell Therapies

Founded in January 2008 in San Diego, California, Animal Cell Therapies (ACT) is the manifestation of veterinarian Dr. Kathryn Petrucci, whose vision is to improve the lives of animals through thoughtful research and development, innovation and strategic partnerships.  At the company’s California-based stem cell research and development facility, the ACT team is focused on developing and delivering revolutionary cellular treatment and services to their customers.  For more information, visit www.actcells.com.